Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Yellow Fever market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.1% during the forecast period.
This report presents the market size and development trends by detailing the Yellow Fever market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Yellow Fever market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Yellow Fever industry and will help you to build a panoramic view of the industrial development.
Yellow Fever Market, By Type:
Monovalent Vaccines
Multivalent Vaccines
Yellow Fever Market, By Application:
Pediatrics
Adults
Some of the leading players are as follows:
Bio-Manguinhos
Johnson & Johnson.
Merck & Co, Inc
Emergent Biosolutions, Inc.
Medimmune, LLC. (A Subsidiary of Astrazeneca)
Sanofi Pasteur
Serum Institute of India.
Medimmune, LLC (A Subsidiary of Astrazeneca)
Merck & Co., Inc.
Astellas Pharma Inc
Glaxosmithkline, PLC.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Yellow Fever Market: Technology Type Analysis
-
4.1 Yellow Fever Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Yellow Fever Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Monovalent Vaccines
4.3.2 Multivalent Vaccines
5 Yellow Fever Market: Product Analysis
-
5.1 Yellow Fever Product Market Share Analysis, 2018 & 2026
-
5.2 Yellow Fever Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Yellow Fever Market: Application Analysis
-
6.1 Yellow Fever Application Market Share Analysis, 2018 & 2026
-
6.2 Yellow Fever Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pediatrics
6.3.2 Adults
7 Yellow Fever Market: Regional Analysis
-
7.1 Yellow Fever Regional Market Share Analysis, 2018 & 2026
-
7.2 Yellow Fever Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Bio-Manguinhos
9.1.1 Bio-Manguinhos Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Johnson & Johnson.
9.2.1 Johnson & Johnson. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Merck & Co, Inc
9.3.1 Merck & Co, Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Emergent Biosolutions, Inc.
9.4.1 Emergent Biosolutions, Inc. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Medimmune, LLC. (A Subsidiary of Astrazeneca)
9.5.1 Medimmune, LLC. (A Subsidiary of Astrazeneca) Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Sanofi Pasteur
9.6.1 Sanofi Pasteur Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Serum Institute of India.
9.7.1 Serum Institute of India. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Medimmune, LLC (A Subsidiary of Astrazeneca)
9.8.1 Medimmune, LLC (A Subsidiary of Astrazeneca) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Merck & Co., Inc.
9.9.1 Merck & Co., Inc. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Astellas Pharma Inc
9.10.1 Astellas Pharma Inc Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Glaxosmithkline, PLC.
9.11.1 Glaxosmithkline, PLC. Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 77 Figures and 131 Tables)
Figure Monovalent Vaccines Yellow Fever market, 2015 - 2026 (USD Million)
Figure Multivalent Vaccines Yellow Fever market, 2015 - 2026 (USD Million)
Figure Pediatrics market, 2015 - 2026 (USD Million)
Figure Adults market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Yellow Fever market, by country, 2015 - 2026 (USD Million)
-
Table North America Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table North America Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table North America Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Canada Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Canada Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Europe Yellow Fever market, by country, 2015 - 2026 (USD Million)
-
Table Europe Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Europe Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Europe Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Germany Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Germany Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table France Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table France Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Italy Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Italy Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Spain Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Spain Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Yellow Fever market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table China Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table China Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Japan Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Japan Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table India Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table India Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Yellow Fever market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table MEA Yellow Fever market, by country, 2015 - 2026 (USD Million)
-
Table MEA Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table MEA Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table MEA Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Yellow Fever market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Yellow Fever market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Yellow Fever market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Bio-Manguinhos Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Emergent Biosolutions, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Serum Institute of India. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medimmune, LLC (A Subsidiary of Astrazeneca) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Astellas Pharma Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Glaxosmithkline, PLC. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
